a clinical-stage biotechnology company, which engages in the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases
Industry Biotechnology
A.I.dvisor indicates that over the last year, CABA has been loosely correlated with PLRX. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if CABA jumps, then PLRX could also see price increases.
Ticker / NAME | Correlation To CABA | 1D Price Change % | ||
---|---|---|---|---|
CABA | 100% | -10.12% | ||
PLRX - CABA | 36% Loosely correlated | -3.84% | ||
SCPX - CABA | 35% Loosely correlated | +1.29% | ||
ENTO - CABA | 33% Poorly correlated | +2.41% | ||
AUTL - CABA | 32% Poorly correlated | -2.04% | ||
ACLX - CABA | 32% Poorly correlated | -3.81% | ||
More |